Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.

about

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.

Item

http://www.wikidata.org/entity/Q40404113

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Extended use of Prostate Healt ...... al digital rectal examination.

@en

type

Item

label

Extended use of Prostate Healt ...... al digital rectal examination.

@en

prefLabel

Extended use of Prostate Healt ...... al digital rectal examination.

@en

P1476

Extended use of Prostate Healt ...... al digital rectal examination.

@en

P2093

Chi-Hang Yee

http://www.w3.org/2001/XMLSchema#string

Eddie Shu-Yin Chan

http://www.w3.org/2001/XMLSchema#string

Peter Ka-Fung Chiu

http://www.w3.org/2001/XMLSchema#string

See-Ming Hou

http://www.w3.org/2001/XMLSchema#string

Wai-Man Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group

Screening and prostate-cancer mortality in a randomized European study

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Decision curve analysis: a novel method for evaluating prediction models

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

The prostate health index selectively identifies clinically significant prostate cancer.

RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings.

P304

336-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4111/ICU.2016.57.5.336

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chi-Fai Ng

Jeremy Teoh

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27617315

http://www.w3.org/2001/XMLSchema#string

P932

5017555

http://www.w3.org/2001/XMLSchema#string